2022
DOI: 10.1016/j.nicl.2022.103256
|View full text |Cite
|
Sign up to set email alerts
|

Increased functional connectivity between nucleus basalis of Meynert and amygdala in cognitively intact elderly along the Alzheimer’s continuum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…With regard to AD, a longitudinal study in humans could show that amygdala degeneration and abnormal memory-related alpha oscillations, as measured with electroencephalography (EEG), predict the conversion to AD (Prieto del Val et al, 2016). Further, fMRI based functional connectivity between the NbM and amygdala during resting state was increased with neuropathology as indicated by amyloid and tau PET (Zeng et al, 2022). This is in line with other PET studies on the spread of amyloid-β and tau (Insel et al, 2020), as well as MRI studies in MCI and AD showing that NbM atrophy covaries with atrophy in innervating regions, including the amygdala (Cantero et al, 2016; Schmitz et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…With regard to AD, a longitudinal study in humans could show that amygdala degeneration and abnormal memory-related alpha oscillations, as measured with electroencephalography (EEG), predict the conversion to AD (Prieto del Val et al, 2016). Further, fMRI based functional connectivity between the NbM and amygdala during resting state was increased with neuropathology as indicated by amyloid and tau PET (Zeng et al, 2022). This is in line with other PET studies on the spread of amyloid-β and tau (Insel et al, 2020), as well as MRI studies in MCI and AD showing that NbM atrophy covaries with atrophy in innervating regions, including the amygdala (Cantero et al, 2016; Schmitz et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…by including preclinical AD cases in the group of healthy controls), the AT(N) framework, which incorporates amyloid-beta (A), tau (T), and neurodegenerative (N), could have been used (Jack et al, 2018). However, in most studies, these markers were not assessed, and larger sample sizes would be necessary to include at least three groups (A-T-, A+T-, A+T+), with typically imbalanced distributions (see, e.g., Zeng et al (2022)). Additionally, other forms of dementia were excluded based on the specified exclusion criteria in BrainMap that were validated by cross-checking the original literature.…”
Section: Discussionmentioning
confidence: 99%